09-May-2016 - Inadequate record keeping at Merck & Co.’s contract manufacturer has delayed the European launch of its hepatitis C drug Zepatier (elbasvir and grazoprevir).
06-Jan-2016 - Merck & Co. has expanded a partnership to use Emulate’s organ-on-chip technology to carry out predictive modelling of inflammatory processes.
16-Nov-2015 - Roche’s exit from four small molecule manufacturing plants will provide opportunities for third-party manufacturers, the firm says.
22-Oct-2015 - As pharma sells off manufacturing capacity and outsources to large and specialist CMOs, smart contract houses will have an opportunity to grab market share in a currently fragmented sector, say...
23-Sep-2015 - Electricity from a ‘green energy’ biomass plant being built nearby will cut utility costs at an Aesica UK facility and help the CDMO stay competitive.
16-Sep-2015 - Danish biotech Bavarian Nordic has signed a $9m contract from Johnson & Johnson to improve stability of their joint Ebola vaccine. After options and milestone awards, payment could total $33m.
20-Aug-2015 - Merck & Co. has recalled two chemotherapy products because of cracked caps, including one it manufactures for Novartis’ Sandoz.
15-May-2015 - Experts across the sponsor-CRO spectrum seem to agree on at least one thing: the clinical trial process is ready for a major transformation, though how quickly and what types of...
27-Apr-2015 - As 20 of the largest biopharma companies have now joined industry group TransCelerate, the group is beginning to use patient centricity and connectivity to influence the clinical trial environment, CEO...
23-Apr-2015 - Merck & Co. has struck a deal with Organovo to use a 3D printed human liver system for toxicology testing as a supplement to in vitro and preclinical animal testing....
05-Mar-2015 - Higher capacity utilization is improving prices across the non-clinical research sector according to Huntingdon Life Sciences CEO Brian Cass, who told Outsourcing-pharma.com the preclinical CRO may add scale to US...
19-Jan-2015 - Novartis will close an OTC plant in Puerto Rico by 2019 and transfer manufacturing and packaging actives to sites in the US and facilities operated by Eli Lilly and Virbac.
06-Jan-2015 - More than a year since its creation , India’s Apex Committee is now calling for developers of cancer treatments approved without trials in India to monitor the first 500 patients to...
20-Nov-2014 - UK life sciences minister George Freeman wants hospitals to play more of a role in clinical trials and says accelerating the drug development process in the post block-buster era is...
24-Sep-2014 - Life science sector consolidation is a concern for some biomanufacturers, who say mega mergers like Merck KGaA’s $17bn acquisition of Sigma-Aldrich will limit their ability to negotiate on prices.
07-Jul-2014 - Merck Millipore, the life sciences tools division of Merck KGaA, has launched a solid dose formulation lab in India, its first outside Europe.
23-Apr-2014 - MSD has selected Catalent to manufacture two recently approved sublingual pollen extract drugs using its Zydis formulation platform.
06-Mar-2014 - Columbia Laboratories has reported strong annual results despite a fourth quarter affected by Actavis taking the manufacture of vaginal gel Crinone in-house and the “lumpiness” of Merck Serono.
15-Jan-2014 - The combination cholesterol drug Liptruzet will be unavailable in the US for the foreseeable future, says Merck & Co., after packaging defect at CMO led to a total product recall.
09-Jan-2014 - Merck Millipore has sold its Discovery and Development Solutions (DDS) Business to Eurofins saying it was unable to fully support.
02-Dec-2013 - Trust, transparency and end-to-end participation are just some of the reasons Merck Serono says its exclusive strategic partnership with Quintiles is the “first of its kind.”
20-Aug-2013 - MSD has extended its branded drug manufacturing partnership with Akrikhin in order to fulfill Pharma 2020 - Russia’s local manufacturing strategy.
01-Jul-2013 - The Aspen Group, a generic pharmaceutical company, is moving further into the manufacturing business with the purchase of Merck’s API manufacturing sites in the Netherlands and Iowa.
16-May-2013 - Just days after raising more than $1B in its IPO, Quintiles announced Wednesday it signed a five-year clinical development agreement with Merck Serono.
20-Mar-2013 - Drugmakers Merck & Co and Eisai have both substantially cut internal data management costs through two unique off-shoring operations in China and India, respectively.